Hims & Hers Health, Inc. (HIMS) — Stock Score Summary

Hims & Hers Health, Inc. (HIMS) has a MoatMap StockRank of 18/100 based on Quality (51/100), Value (24/100), and Momentum (30/100) factor scores. The current signal is STRONG SELL. While Hims & Hers has shown strong consumer demand, its low value score (V: 26) and strong sell signal suggest the market has priced in growth, while regulatory risks around compounded GLP-1s present a major near-term overhang.

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform providing personalized health and wellness products and services directly to consumers, including prescription medications for conditions like hair loss, sexual health, and mental well-being. The company leverages a digital-first, subscription-based model to increase access to affordable healthcare solutions. Its competitive advantage is driven by its strong brand, user-friendly platform, and comprehensive product offerings in a rapidly expanding telehealth market.

Key Financial Metrics

Price$28.98
Market Cap$5.9B
P/E (Forward)21.77
Price/Book14.48
Return on Equity-2.7%
Return on Invested Capital6.0%
Debt/Equity253.72
Gross Margin72.9%
Operating Margin-7.9%
Revenue Growth3.8%
Free Cash Flow$174M

Hims & Hers Health, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Hims & Hers Health, Inc.’s (HIMS) StockRank?
MoatMap’s StockRank for Hims & Hers Health, Inc. (HIMS) is 18/100, with a Strong Sell signal. It is a composite of Quality (51), Value (24), and Momentum (30) factor ranks across MoatMap’s 19,000+ stock universe.
Does Hims & Hers Health, Inc. have an economic moat?
Hims & Hers Health, Inc. (HIMS) has a Quality factor score of 51/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Hims & Hers Health, Inc. a buy, hold, or sell?
MoatMap’s current signal for Hims & Hers Health, Inc. (HIMS) is Strong Sell, based on a StockRank of 18/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Hims & Hers Health, Inc. in?
Hims & Hers Health, Inc. (HIMS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).
Browse all ranked stocksHIMS deep dive reportAI ChampionsHow we score stocksSense-check another stock